Birring SS on Muck Rack

Birring SS

As seen in: Medthority
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Birring

Contact Birring, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials

|
By McGarvey LP, Birring SS, Morice AH, Dicpinigaitis PV
| Medthority
Home / Journals / Chronic Cough / Efficacy and safety of gefapixant, a P2X3 receptor... Journal Read time: 2 mins Published:4th Mar 2023 Author: McGarvey LP, Birring SS, Morice AH, Dicpinigaitis PV, Pavord ID, Schelfhout J et al. Availability: Pay for access, or by subscription Ref.:Lancet. 2022 Mar 5;399(10328):909-923. DOI:10.1016/S0140-6736(21)02348-5 Register for free access to this exclusive healthcare learning resource Why sign up with Medthority?
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified